Sam Park Insider Profile
4 Followers
Sam Park, General Counsel at Hikma Pharmaceuticals, holds ― shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Sam Park has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Sam Park does not currently own shares as a corporate insider.
A breakdown of Sam Park's holdings
Insider Roles
General Counsel
Roles that Sam Park holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Sam Park
Sam Park's Trading History
List of latest transactions for each holding click on a transaction to see Sam Park's performance on stock
You May Also Like
Sam Park insider profile FAQ
What is the percentage of profitable transactions made by Sam Park?
The percentage of profitable transactions made by Sam Park is ―.
What is the average return per transaction made by Sam Park?
The average return per transaction made by Sam Park is ―.
What stocks does Sam Park hold?
Sam Park holds: GB:HIK stocks.
What was Sam Park’s latest transaction?
Sam Park latest transaction was an Uninformative Buy of ―.
What was Sam Park's most profitable transaction?
Sam Park’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Sam Park's role in Hikma Pharmaceuticals?
Sam Park's role in Hikma Pharmaceuticals is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.